NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 237 | -5.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 250 | -37.5% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 400 | +1042.9% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 35 | -45.3% | 0.00% | – |
| Q1 2020 | $2,000 | – | 64 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $21,000 | -43.2% | 619 | -43.6% | 0.00% | +50.0% |
| Q4 2018 | $37,000 | -78.1% | 1,097 | -60.5% | 0.00% | -71.4% |
| Q3 2018 | $169,000 | +108.6% | 2,775 | +67.8% | 0.01% | +133.3% |
| Q2 2018 | $81,000 | -19.8% | 1,654 | -2.4% | 0.00% | -40.0% |
| Q1 2018 | $101,000 | 0.0% | 1,694 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $101,000 | +152.5% | 1,694 | +0.5% | 0.01% | +150.0% |
| Q3 2017 | $40,000 | +21.2% | 1,686 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $33,000 | -45.9% | 1,686 | -34.8% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +205.0% | 2,586 | +55.3% | 0.00% | +200.0% |
| Q4 2016 | $20,000 | -28.6% | 1,665 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | +33.3% | 1,653 | +10.2% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | 0.0% | 1,500 | +142.3% | 0.00% | -66.7% |
| Q1 2016 | $21,000 | -22.2% | 619 | -61.0% | 0.00% | +50.0% |
| Q4 2015 | $27,000 | – | 1,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |